ブプロフェジン市場：配合、害虫、作物タイプ別-2025～2030年の世界予測

ブプロフェジン市場は、2023年に7億2,510万米ドルと評価され、2024年には7億6,259万米ドルに達すると予測され、CAGR 5.28%で成長し、2030年には10億3,958万米ドルに達すると予測されています。

ブプロフェジンは、主に稲、綿花、果物などの作物の害虫駆除に使用される殺虫剤で、農業において重要な役割を果たしています。その主要用途は、昆虫の外骨格形成に不可欠なキチンの合成を阻害することにより、昆虫の開発を阻害することです。ブプロフェジンの必要性は、作物を確実に保護し、収穫の質を高める効果的な害虫管理ソリューションに対する需要の高まりから生じています。その用途は、主に害虫の蔓延に悩まされる湿度の高い亜熱帯地域など、さまざまな農業領域にわたっています。最終用途の範囲には、主に農業部門、特に穀物、果物、野菜の栽培が含まれます。

市場洞察によると、世界の食糧需要の増加と耕地面積の減少が相まって、農業従事者は生産量を最大化する必要に迫られており、それがブプロフェジンの需要を促進しています。さらに、総合的害虫管理に対する意識の高まりと採用が、効率的な害虫駆除ソリューションの重要性を強調し、市場成長の大きな機会となっています。サステイナブル農業を奨励する規制の枠組みは、その使用をさらに促進しています。しかし、厳しい環境規制、抵抗性害虫の潜在的な市場開拓、他の害虫駆除剤との競合といった課題は、市場の発展を妨げる可能性があります。こうした課題には、有効性と持続可能性を高めるための製剤技術や散布方法の革新が必要です。

残留効果を高め、環境への影響を低減し、他の作物への適用範囲を拡大するような、新規の製剤を探求することにこそ機会があります。有効性を拡大するための他の生物農薬との相乗的組み合わせや、放出制御型製剤の探求に重点を置いた調査が可能であると考えられます。さらに、デジタル農業と精密農業は、散布の精度と効率を向上させる道を記載しています。市場が進化を続ける中、利害関係者は新たな動向に適応し市場抑制要因を克服するため、多様化戦略、パートナーシップ、研究開発への投資に注力すべきです。このようなアプローチは、進化する農業情勢に対応し、持続的な成長を達成するために不可欠です。

市場力学：急速に進化するブプロフェジン市場における主要市場洞察の解明

ブプロフェジン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 増大する食糧需要を満たすための作物収量の増加に対するニーズの高まり
  • 環境的にサステイナブル害虫駆除方法を重視する規制の高まり
• 市場抑制要因
  • ブプロフェジンの使用による環境問題への懸念
• 市場機会
  • ブプロフェジン製剤を強化するための継続的な研究開発活動
  • 総合的有害生物管理（IPM）手法や精密農業へのシフトの高まり
• 市場課題
  • 規制上の制約と従来の殺虫剤に対する害虫の抵抗性の高まり

ポーターのファイブフォース：ブプロフェジン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ブプロフェジン市場における外部からの影響の把握

外部マクロ環境要因は、ブプロフェジン市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：ブプロフェジン市場における競合情勢の把握

ブプロフェジン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：ブプロフェジン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ブプロフェジン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：ブプロフェジン市場における成功への道筋を描く

ブプロフェジン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 増大する食糧需要を満たすために、作物の収穫量を増やす必要性が高まっている
    • 環境的にサステイナブル害虫駆除方法に対する規制の強化
  • 抑制要因
    • ブプロフェジンの使用に関する環境問題
  • 機会
    • ブプロフェジン配合の強化に向けた継続的な研究開発活動
    • 総合的病害虫管理（IPM）の実践と精密農業への移行の拡大
  • 課題
    • 規制上の制約と従来の殺虫剤に対する害虫の耐性の増大
• 市場セグメンテーション分析
  • 配合：標的外への移動の可能性を減らすために、懸濁液濃縮製剤の使用が増加
  • 作物タイプ：果物や野菜の栽培におけるブプロフェジンの高いポテンシャルにより、品質と収穫量を維持できる
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 ブプロフェジン市場：配合別

• イントロダクション
• ドリフトレス配合
• 乳剤
• 懸濁液濃縮液
• 水分散性顆粒
• 水和剤

第7章 ブプロフェジン市場：害虫別

• イントロダクション
• ウンカ
• キジラミ
• カイガラムシ
• コナジラミ

第8章 ブプロフェジン市場：作物タイプ別

• イントロダクション
• 穀類・穀物
• 果物・野菜

第9章 南北アメリカのブプロフェジン市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のブプロフェジン市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのブプロフェジン市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Nichino AmericaとSipcamが新たなクロスライセンス契約を締結、米国におけるフェンピロキシメートとブプロフェジンの市場シェア拡大へ
  • Insecticides India、ラジャスタン州とグジャラート州で生産能力を拡大、15億インドルピーを投資
• 戦略分析と提言

企業一覧

• Albaugh LLC
• Anmol BIoTech Private Limited
• Aristo Bio-tech And Lifescience Limited
• Bayer AG
• Bharat Group
• Biostadt India Limited
• Canary Agro Chemicals Private Limited
• Croda International PLC
• Dhanuka Agritech Limited
• Hebei Enge BIoTech Co., Ltd.
• Insecticides (India) Limited
• Jaffer Group
• Jaivik Crop Care LLP
• Kenvos AG
• King Quenson Group
• Merck KGaA
• Nihon Nohyaku Co., Ltd.
• Nova Agritech Limited
• Paras Crops Limited
• Parijat Industries India Pvt. Ltd.
• Rallis India Limited by Tata Chemicals Limited
• Sumitomo Chemical Co., Ltd..
• Thermo Fisher Scientific Inc.
• UPL Ltd.
• Zagro

LIST OF FIGURES

• FIGURE 1. BUPROFEZIN MARKET RESEARCH PROCESS
• FIGURE 2. BUPROFEZIN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BUPROFEZIN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BUPROFEZIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BUPROFEZIN MARKET SIZE, BY PEST, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BUPROFEZIN MARKET SIZE, BY PEST, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BUPROFEZIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BUPROFEZIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BUPROFEZIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BUPROFEZIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BUPROFEZIN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BUPROFEZIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BUPROFEZIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BUPROFEZIN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BUPROFEZIN MARKET DYNAMICS
• TABLE 7. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BUPROFEZIN MARKET SIZE, BY DRIFT LESS FORMULATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BUPROFEZIN MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BUPROFEZIN MARKET SIZE, BY PLANTHOPPERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BUPROFEZIN MARKET SIZE, BY PSYLLIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BUPROFEZIN MARKET SIZE, BY SCALE INSECTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BUPROFEZIN MARKET SIZE, BY WHITEFLIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BUPROFEZIN MARKET SIZE, BY CEREALS & GRAINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 33. CANADA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BUPROFEZIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 50. CHINA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 53. INDIA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 105. ITALY BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 117. POLAND BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 120. QATAR BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM BUPROFEZIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM BUPROFEZIN MARKET SIZE, BY PEST, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2030 (USD MILLION)
• TABLE 148. BUPROFEZIN MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. BUPROFEZIN MARKET, FPNV POSITIONING MATRIX, 2023

The Buprofezin Market was valued at USD 725.10 million in 2023, expected to reach USD 762.59 million in 2024, and is projected to grow at a CAGR of 5.28%, to USD 1,039.58 million by 2030.

Buprofezin, an insecticide used primarily for controlling pests in crops such as rice, cotton, and fruits, plays a crucial role in agriculture. Its main utility is in inhibiting the development of insects by interfering with chitin synthesis, essential for their exoskeleton formation. The necessity of buprofezin arises from the growing demand for effective pest management solutions that ensure crop protection and enhance yield quality. Its application extends across various agricultural domains, mainly in humid and sub-tropical regions plagued by pest infestations. The end-use scope primarily includes the agriculture sector, especially in the cultivation of grain, fruits, and vegetables.

Market insights suggest that the increasing global food demand, coupled with a decrease in arable land, pressures farmers to maximize their output, thereby driving the demand for buprofezin. Additionally, the rising awareness and adoption of integrated pest management practices underscore the importance of efficient insect control solutions, presenting significant opportunities for market growth. Regulatory frameworks encouraging sustainable farming further amplify its use. However, challenges such as stringent environmental regulations, potential development of resistant pest strains, and competition from other pest control alternatives may hinder market progress. These challenges necessitate innovation in formulation techniques and application methods to enhance efficacy and sustainability.

Opportunities lie in exploring novel formulations that increase residue effectiveness, reduce environmental impact, and expand its application spectrum to other crops. Research efforts could focus on synergistic combinations with other biopesticides to extend efficacy and the exploration of controlled-release formulations. Additionally, digital farming and precision agriculture offer avenues to improve application accuracy and efficiency. As the market continues to evolve, stakeholders should focus on diversification strategies, partnerships, and investments in research and development to adapt to emerging trends and overcome market constraints. This approach will be critical for tapping into the evolving agricultural landscape and achieving sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Buprofezin Market

The Buprofezin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing need for higher crop yields to meet growing food demand
  • Growing regulatory emphasis on environmentally sustainable pest control methods
• Market Restraints
  • Environmental concerns with the usage of buprofezin
• Market Opportunities
  • Continuous R&D activities for enhancing buprofezin formulations
  • Growing shift towards integrated pest management (IPM) practices and precision agriculture
• Market Challenges
  • Regulatory constraints and the growing resistance of pests to conventional insecticides

Porter's Five Forces: A Strategic Tool for Navigating the Buprofezin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Buprofezin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Buprofezin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Buprofezin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Buprofezin Market

A detailed market share analysis in the Buprofezin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Buprofezin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Buprofezin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Buprofezin Market

A strategic analysis of the Buprofezin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Buprofezin Market, highlighting leading vendors and their innovative profiles. These include Albaugh LLC, Anmol Biotech Private Limited, Aristo Bio-tech And Lifescience Limited, Bayer AG, Bharat Group, Biostadt India Limited, Canary Agro Chemicals Private Limited, Croda International PLC, Dhanuka Agritech Limited, Hebei Enge Biotech Co., Ltd., Insecticides (India) Limited, Jaffer Group, Jaivik Crop Care LLP, Kenvos AG, King Quenson Group, Merck KGaA, Nihon Nohyaku Co., Ltd., Nova Agritech Limited, Paras Crops Limited, Parijat Industries India Pvt. Ltd., Rallis India Limited by Tata Chemicals Limited, Sumitomo Chemical Co., Ltd.., Thermo Fisher Scientific Inc., UPL Ltd., and Zagro.

Market Segmentation & Coverage

This research report categorizes the Buprofezin Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Formulation, market is studied across Drift Less Formulation, Emulsifiable Concentrate, Suspension Concentrate, Water Dispersible Granules, and Wettable Powder.
• Based on Pest, market is studied across Planthoppers, Psyllids, Scale Insects, and Whiteflies.
• Based on Crop Type, market is studied across Cereals & Grains and Fruits & Vegetables.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing need for higher crop yields to meet growing food demand
    • 5.1.1.2. Growing regulatory emphasis on environmentally sustainable pest control methods
  • 5.1.2. Restraints
    • 5.1.2.1. Environmental concerns with the usage of buprofezin
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous R&D activities for enhancing buprofezin formulations
    • 5.1.3.2. Growing shift towards integrated pest management (IPM) practices and precision agriculture
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory constraints and the growing resistance of pests to conventional insecticides
• 5.2. Market Segmentation Analysis
  • 5.2.1. Formulation: Growing usage of suspension concentrate formulations to reduce the potential for off-target movement
  • 5.2.2. Crop Type: High potential of buprofezin for growing fruits & vegetable crops to sustain the quality and yield
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Buprofezin Market, by Formulation

• 6.1. Introduction
• 6.2. Drift Less Formulation
• 6.3. Emulsifiable Concentrate
• 6.4. Suspension Concentrate
• 6.5. Water Dispersible Granules
• 6.6. Wettable Powder

7. Buprofezin Market, by Pest

• 7.1. Introduction
• 7.2. Planthoppers
• 7.3. Psyllids
• 7.4. Scale Insects
• 7.5. Whiteflies

8. Buprofezin Market, by Crop Type

• 8.1. Introduction
• 8.2. Cereals & Grains
• 8.3. Fruits & Vegetables

9. Americas Buprofezin Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Buprofezin Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Buprofezin Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Nichino America and Sipcam Signed Another Cross-License Agreement, Which will Increase the Market Share of Fenpyroximate and Buprofezin in the United States
  • 12.3.2. Insecticides India To Expand Capacity In Rajasthan, Gujarat, Will Invest INR 150 Crore
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Albaugh LLC
• 2. Anmol Biotech Private Limited
• 3. Aristo Bio-tech And Lifescience Limited
• 4. Bayer AG
• 5. Bharat Group
• 6. Biostadt India Limited
• 7. Canary Agro Chemicals Private Limited
• 8. Croda International PLC
• 9. Dhanuka Agritech Limited
• 10. Hebei Enge Biotech Co., Ltd.
• 11. Insecticides (India) Limited
• 12. Jaffer Group
• 13. Jaivik Crop Care LLP
• 14. Kenvos AG
• 15. King Quenson Group
• 16. Merck KGaA
• 17. Nihon Nohyaku Co., Ltd.
• 18. Nova Agritech Limited
• 19. Paras Crops Limited
• 20. Parijat Industries India Pvt. Ltd.
• 21. Rallis India Limited by Tata Chemicals Limited
• 22. Sumitomo Chemical Co., Ltd..
• 23. Thermo Fisher Scientific Inc.
• 24. UPL Ltd.
• 25. Zagro